Mark Sherer1, Todd G Nick, Angelle M Sander, Maria Melguizo, Robin Hanks, Thomas A Novack, David Tulsky, Pamela Kisala, Chunqiao Luo, Xinyu Tang. 1. TIRR Memorial Hermann, Houston, Texas (Drs Sherer and Sander); Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, Texas (Drs Sherer and Sander); Department of Pediatrics and Biostatistics, University of Arkansas for Medical Sciences, Little Rock (Drs Nick and Tang and Mss Melguizo and Luo); Department of Physical Medicine and Rehabilitation/Center for Trauma Rehabilitation, Harris Health System, Houston, Texas (Dr Sander); Department of Physical Medicine and Rehabilitation, Wayne State University Medical School, Rehabilitation Institute of Michigan, Detroit (Dr Hanks); Department of Physical Medicine and Rehabilitation, University of Alabama at Birmingham (Dr Novack); Department of Physical Therapy, University of Delaware College of Health Sciences, Newark (Dr Tulsky and Ms Kisala); and Kessler Foundation, West Orange, New Jersey (Dr Tulsky). †Deceased.
Abstract
OBJECTIVE: To (1) identify groups of persons with traumatic brain injury (TBI) who differ on 12 dimensions of cognitive function: cognitive, emotional, and physical symptoms; personal strengths; physical functioning; environmental supports; and performance validity; and (2) describe patterns of differences among the groups on these dimensions and on participation outcome. SETTING: Three centers for rehabilitation of persons with TBI. PARTICIPANTS: A total of 504 persons with TBI living in the community who were an average (standard deviation) of 6.3 (6.8) years postinjury and who had capacity to give consent, could be interviewed and tested in English, and were able to participate in an assessment lasting up to 4 hours. DESIGN: Observational study of a convenience sample of persons with TBI. MAIN MEASURES: Selected scales from the Traumatic Brain Injury Quality of Life measures, Neurobehavioral Symptom Inventory, Economic Quality of Life Scale, Family Assessment Device General Functioning Scale, measures of cognitive function, Word Memory Test, and Participation Assessment with Recombined Tools-Objective (PART-O) scale. RESULTS: Cluster analysis identified 5 groups of persons with TBI who differed in clinically meaningful ways on the 12 dimension scores and the PART-O scale. CONCLUSION: Cluster groupings identified in this study could assist clinicians with case conceptualization and treatment planning.
OBJECTIVE: To (1) identify groups of persons with traumatic brain injury (TBI) who differ on 12 dimensions of cognitive function: cognitive, emotional, and physical symptoms; personal strengths; physical functioning; environmental supports; and performance validity; and (2) describe patterns of differences among the groups on these dimensions and on participation outcome. SETTING: Three centers for rehabilitation of persons with TBI. PARTICIPANTS: A total of 504 persons with TBI living in the community who were an average (standard deviation) of 6.3 (6.8) years postinjury and who had capacity to give consent, could be interviewed and tested in English, and were able to participate in an assessment lasting up to 4 hours. DESIGN: Observational study of a convenience sample of persons with TBI. MAIN MEASURES: Selected scales from the Traumatic Brain Injury Quality of Life measures, Neurobehavioral Symptom Inventory, Economic Quality of Life Scale, Family Assessment Device General Functioning Scale, measures of cognitive function, Word Memory Test, and Participation Assessment with Recombined Tools-Objective (PART-O) scale. RESULTS: Cluster analysis identified 5 groups of persons with TBI who differed in clinically meaningful ways on the 12 dimension scores and the PART-O scale. CONCLUSION: Cluster groupings identified in this study could assist clinicians with case conceptualization and treatment planning.
Authors: Pamela A Kisala; Aaron J Boulton; Matthew L Cohen; Mary D Slavin; Alan M Jette; Susan Charlifue; Robin Hanks; M J Mulcahey; David Cella; David S Tulsky Journal: Health Psychol Date: 2019-05 Impact factor: 4.267
Authors: Mark Sherer; Angelle M Sander; Jennie Ponsford; Leia Vos; Julia M P Poritz; Esther Ngan; Luis Leon Novelo Journal: J Int Neuropsychol Soc Date: 2020-05-27 Impact factor: 2.892
Authors: Benjamin L Brett; Mark D Kramer; John Whyte; Michael A McCrea; Murray B Stein; Joseph T Giacino; Mark Sherer; Amy J Markowitz; Geoffrey T Manley; Lindsay D Nelson; Opeolu Adeoye; Neeraj Badjatia; Kim Boase; Jason Barber; Yelena Bodien; M Ross Bullock; Randall Chesnut; John D Corrigan; Karen Crawford; Ramon Diaz-Arrastia; Sureyya Dikmen; Ann-Christine Duhaime; Richard Ellenbogen; V Ramana Feeser; Adam R Ferguson; Brandon Foreman; Raquel Gardner; Etienne Gaudette; Luis Gonzalez; Shankar Gopinath; Rao Gullapalli; J Claude Hemphill; Gillian Hotz; Sonia Jain; C Dirk Keene; Frederick K Korley; Joel Kramer; Natalie Kreitzer; Harvey Levin; Chris Lindsell; Joan Machamer; Christopher Madden; Alastair Martin; Thomas McAllister; Randall Merchant; Pratik Mukherjee; Laura B Ngwenya; Florence Noel; David Okonkwo; Eva Palacios; Ava Puccio; Miri Rabinowitz; Claudia Robertson; Jonathan Rosand; Angelle Sander; Gabriella Satris; David Schnyer; Seth Seabury; Sabrina Taylor; Nancy Temkin; Arthur Toga; Alex Valadka; Mary Vassar; Kevin Wang; John K Yue; Esther Yuh; Ross Zafonte Journal: JAMA Netw Open Date: 2021-03-01
Authors: Mary Jo Pugh; Eamonn Kennedy; Eric M Prager; Jeffrey Humpherys; Kristen Dams-O'Connor; Dallas Hack; Mary Katherine McCafferty; Jessica Wolfe; Kristine Yaffe; Michael McCrea; Adam R Ferguson; Lee Lancashire; Jamshid Ghajar; Angela Lumba-Brown Journal: J Neurotrauma Date: 2021-06-10 Impact factor: 5.269